Agios Pharmaceuticals
AGIO
#5027
Rank
โ‚น183.24 B
Marketcap
โ‚น3,069
Share price
1.50%
Change (1 day)
-15.41%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -โ‚น42.08 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น98.33 Million. In 2025 the company made an earning of -โ‚น45.69 Billion a decrease over its 2024 earnings that were of -โ‚น41.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น42.08 Billion-7.9%
2025 -โ‚น45.69 Billion10.9%
2024 -โ‚น41.2 Billion8.75%
2023 -โ‚น37.89 Billion0.63%
2022 -โ‚น37.65 Billion2.81%
2021 -โ‚น36.62 Billion10.58%
2020 -โ‚น33.12 Billion-18.41%
2019 -โ‚น40.59 Billion15.72%
2018 -โ‚น35.08 Billion12.99%
2017 -โ‚น31.05 Billion59.61%
2016 -โ‚น19.45 Billion69.32%
2015 -โ‚น11.49 Billion119.28%
2014 -โ‚น5.24 Billion39.22%
2013 -โ‚น3.77 Billion69.1%
2012 -โ‚น2.23 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น668.35 B-1,604.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.250 T-7,418.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น763.42 B-1,818.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-โ‚น15.57 Billion-64.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น100.19 B-325.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น14.42 B-132.48%๐Ÿ‡บ๐Ÿ‡ธ USA